Physician profile
Robert K Fullick
NPI 1740476191
$136,607.77
in general payments reported to CMS, 2019-2025
30 companies · $19K in 2025
The $19K reported for 2025 was more than what 90% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77K · 2020: $7,516 · 2021: $15K · 2022: $3,146 · 2023: $3,672 · 2024: $11K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Food and Beverage: $6,995 · Travel and Lodging: $5,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,749.50 |
| Food and Beverage | $6,994.92 |
| Travel and Lodging | $5,269.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $59,755.12 | 2019-2022 | |
| Fx Shoulder Solutions, INC | $28,014.45 | 2021-2025 | |
| Limacorporate S.P.A. | $20,793.25 | 2019-2023 | Smr Shoulder |
| Lima USA, INC. | $10,115.55 | 2019-2023 | Smr Shoulder |
| Medinc of Texas | $6,855.23 | 2019-2025 | |
| Kci USA, INC. | $4,675.00 | 2021 | |
| Arthrex, INC. | $2,463.27 | 2022-2024 | Arthrex |
| Smith+Nephew, INC. | $844.95 | 2024 | Aetos Shoulder System, Twinfix, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Applied Medical Resources Corporation | $562.50 | 2022 | |
| Catalyst Orthoscience | $376.25 | 2019-2022 | |
| Shoulder Innovations, INC. | $226.47 | 2025 | Inset System |
| Zimmer Biomet Holdings, INC. | $224.93 | 2019-2023 | Tapestry |
| Arthrosurface Incorporated | $221.14 | 2019-2025 | Ovomotion, Revomotion, Wristmotion Wrist Hemiarthroplasty System |
| Stryker Corporation | $209.96 | 2024-2025 | Alphavent, Aequalis Perform Reversed, Aequalis Perform+ |
| Integrity Orthopaedics, INC. | $179.02 | 2024 | Integrity Orthopaedics |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $175.14 | 2023-2024 | Surgx, Blastx, Xperience |
| Anika Therapeutics, INC. | $147.99 | 2025 | Integrity Implant |
| Fh Orthopedics, INC. | $122.92 | 2021 | |
| Alafair Biosciences, INC. | $115.09 | 2023-2024 | Versawrap |
| Innovation Technologies INC | $92.81 | 2022 | |
| Osteoremedies, LLC | $88.15 | 2025 | Osteoboost Select 5cc, Remedy Spectrum Gv Spacer, Biowash Surgical Irrigation |
| Pacira Pharmaceuticals Incorporated | $62.51 | 2020-2025 | Exparel, Iovera, Zilretta |
| Horizon Therapeutics Plc | $62.36 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $59.97 | 2022 | |
| Depuy Synthes Sales INC. | $42.42 | 2019 | |
| Avanos Medical | $35.73 | 2025 | On-Q Pump and Accessories |
| Bioventus LLC | $31.25 | 2022 | |
| Sanara Medtech INC. | $26.37 | 2024 | Celleraterx |
| Convatec INC. | $14.42 | 2023 | |
| Fidia Pharma USA INC. | $13.55 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$88,336.91 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Fullick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.